|Mr. Francis R. Amato||CEO & Director||866.52k||N/A||1964|
|Mr. Joseph P. Errico||Co-Founder, Principal Investor & Director||685.19k||N/A||1969|
|Dr. Thomas J. Errico||Director||27.69k||N/A||1952|
|Dr. Peter S. Staats||Sr. Exec. Advisor of Medical & Gov. Affairs||463.73k||N/A||1964|
|Mr. Brian M. Posner||CFO & Corp. Sec.||N/A||N/A||1962|
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
electroCore, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 6.